Rexatilux

ranibizumab · Intas Third Party Sales 2005 S.L.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rexatilux, covering 2026-07-03 to 2026-07-03. Get the full timeline:

Most recent: EMA Authorised: Rexatilux (ranibizumab) — Intas Third Party Sales 2005 S.L.